Items Tagged ‘infectious disease’
March 23, 2022
By Susan Murphy 
A growing number of people are dying from antibiotic-resistant infections. These infections are fueled by microbial species that are mutating to evade the drugs developed to destroy them. More than 1.2 million people worldwide died in 2019 from antibiotic-resistant infections. In response, a team of researchers from Mayo Clinic’s Center for Individualized Medicine has developed a sequencing technology to […]
Tags: antibacterial resistance, antibiotic, Center for Individualized Medicine, DNA, Emma Whittle, genomics, gut health, infection, infectious disease, microbiome, RNA
August 2, 2021
Mayo Clinic Research in the news — 8/2/2021
By Advancing the Science contributor
Readers can try a bit of a scavenger hunt this week. All these news stories feature Mayo Clinic research or research expertise. Physicians and scientists are quoted from across Mayo Clinic and throughout Mayo Clinic Health System. Obesity, diabetes, IBD, sports medicine, infectious diseases, population health and a dozen other topics are covered. Washington Post, […]
Tags: AFib, anxiety, artificial intelligence, atrial fibrillation, colorectal cancer, COVID-19, electronic health record, epilepsy, genetics, Gregory Poland, hereditary diseases, hypertension
July 14, 2021
Mayo Clinic research in the news — 7/12/2021
By Advancing the Science contributor
Research and expertise from Mayo Clinic have been in the news on topics from marijuana, sleep, disparities, dementia and doses of vaccine. Read more. New York Times, Can Marijuana Make You a Better Athlete? … “If you look at any test of physical performance, there’s either no data, it’s a wash, or marijuana makes it worse,” […]
Tags: addiction research, alcoholism, Alejandro Rabinstein, Alyx Porter, Alzheimer's disease, artificial intelligence, autoimmune disorder, Bhanu Kolla, breast cancer, cancer vaccine, cardiology, Center for Individualized Medicine
June 28, 2021
Mayo Clinic Research in the news — 6/28/2021
By Advancing the Science contributor
Vaping, medical AI, the challenges of serving patients with cancer and diabetes, current COVID-19 vaccine and long haul information, and a wide selection of other topics are covered in this week’s news. The Vaping Study You Haven’t Heard Of Slate, 6/25/2021 A report from the Mayo Clinic looked at 70,000 patients and found no link […]
Tags: Alzheimer's disease, antibodies, artificial intelligence, Ashley Wentworth, autoimmune disorder, Barbara Barry, bioethics, biomedical ethics, cancer, cardiovascular disease, Center for Regenerative Medicine, COVID-19
April 19, 2021
Mayo Clinic Research in the news — 4/19/2021
This week saw some advances in neurology for patients with memory loss or Parkinson’s disease, as well as furthered understanding of the role race plays in personalized medicine. Read about these, updates on COVID-19, and a number of other findings in health care and biomedical research. Blood-Based Markers Tied to Brain Cell and Memory Loss […]
Tags: acute kidney injury, Amaal Starling, artificial intelligence, brain cancer, brain tumor, chronic kidney disease, clinical trials, cognitive impairment, concussion, COVID-19, Cumara O'Carroll, diversity
April 18, 2021
Experts propose shared decision making to decrease COVID-19 vaccine hesitancy
The COVID-19 pandemic has lasted more than a year, but hope is here in the form of multiple safe and effective vaccines authorized for emergency use. Millions are now being vaccinated, but as vaccine supply continues to increase throughout 2021, a hurdle health experts anticipate eventually is a lack of public demand. That is, how […]
Tags: COVID-19, Gregory Poland, infectious disease, shared decision making, vaccine hesitancy, vaccines
December 7, 2020
Mayo Clinic Research in the news — 12/7/2020
Lots of chatter last week on COVID-19 and the pending arrival of a vaccine(s). Our researchers and clinicians agree that vaccines are a useful part of our toolbox for fighting infectious disease, and have high hopes for effective reduction of the risks of COVID-19 through widespread vaccination. Other research that made the top of the […]
Tags: Alfredo Quinones-Hinojosa, Alzheimer's disease, artificial intelligence, cancer, Center for the Science of Health Care Delivery, clinical trials, COVID-19, dementia, Erin Barreto, Gregory Poland, infectious disease, Kern Health Care Delivery Scholars
November 23, 2020
Mayo Clinic Research in the news — 11/23/2020
There were all sorts of different things in the news this week, but perhaps the most heartening was the news from Dr. Anthony Fauci and our own Gregory Poland, M.D., that Santa Claus and the elves are practicing safe behaviors and COVID-19 won’t stop Christmas from arriving. Read on for excerpts from this and other […]
Tags: Amir Lerman, Andrew Badley, Anna Subramaniam, antibiotic, antibodies, anxiety, autism, cardiovascular medicine, clinical research, COVID-19, depression, DNA
November 2, 2020
Mayo Clinic Research in the news — 11/2/2020
If you spend any time reading or listening to health care news, you know that some of the same stories are still making their way around the world as last week or even from several weeks back. You may see some repeats from a different news outlet here, but we hope that most of the […]
Tags: Adrian Vella, Amy Oxentenko, artificial intelligence, breast cancer, cancer, cardiology, Center for Clinical and Translational Science, clinical research, COVID-19, depression, education, gastroenterology
October 26, 2020
Mayo Clinic Research in the news — 10/26/2020
At Mayo Clinic, patient care is evidence-based, meaning research drives the practice of medicine. Our scientists and clinician researchers are at work across the spectrum of health and the delivery of health care, seeking better outcomes and enhanced experiences while managing the total costs of care. Curable dementia, pot and opioids, childcare during COVID-19, and […]
Tags: Alzheimer's disease, Andrew Badley, artificial intelligence, autoimmune disorder, biomarkers, cardiovascular medicine, Charles Adler, clinical research, clinical trials, COVID-19, David Knopman, dementia